Literature DB >> 10981117

Hypertension in pregnancy: new recommendations for management.

R Shear1, L Leduc, E Rey, J M Moutquin.   

Abstract

Hypertension in pregnancy is a frequent complication that has substantial adverse perinatal outcomes. Hypertension may be preexisting (chronic) essential or secondary hypertension; a second entity is pregnancy induced (gestational hypertension, preeclampsia). Recent advances have identified newer markers for pregnancy hypertension: several potential candidate genes may explain the apparent family inheritance of preeclampsia, and some thrombophilic markers have been associated with the condition. Management options for mild to moderate hypertension include a short hospital stay to exclude ongoing severe hypertension and to ascertain fetal well-being. Outpatient care with appropriate maternal and fetal surveillance, including umbilical artery doppler velocimetry, is recommended for better perinatal outcomes. Acute care for severe hypertension includes the use of magnesium sulfate to prevent eclampsia and antihypertensive medication. Expeditious delivery is recommended when the maternal or fetal states cannot be stabilized. Follow-up after delivery allows the uncovering of any other coexisting hypertensive or cardiovascular disorder.

Entities:  

Mesh:

Year:  1999        PMID: 10981117     DOI: 10.1007/s11906-996-0026-7

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  89 in total

1.  Impact of reverse end-diastolic flow velocity in umbilical artery on pregnancy outcome after the 28th gestational week.

Authors:  K G Wang; C P Chen; J M Yang; T H Su
Journal:  Acta Obstet Gynecol Scand       Date:  1998-05       Impact factor: 3.636

2.  Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia.

Authors:  S Sohda; T Arinami; H Hamada; N Yamada; H Hamaguchi; T Kubo
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

3.  The remote prognosis of eclamptic women. Sixth periodic report.

Authors:  L C Chesley; J E Annitto; R A Cosgrove
Journal:  Am J Obstet Gynecol       Date:  1976-03-01       Impact factor: 8.661

4.  Platelet angiotensin II binding sites and early detection of preeclampsia.

Authors:  L Pouliot; J C Forest; J M Moutquin; N Coulombe; J Massé
Journal:  Obstet Gynecol       Date:  1998-04       Impact factor: 7.661

5.  Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome.

Authors:  A C Bolte; J van Eyck; H H Kanhai; H W Bruinse; H P van Geijn; G A Dekker
Journal:  Am J Obstet Gynecol       Date:  1999-02       Impact factor: 8.661

6.  Resistance to activated protein C and the leiden mutation: high prevalence in patients with abruptio placentae.

Authors:  Z Wiener-Megnagi; I Ben-Shlomo; Y Goldberg; E Shalev
Journal:  Am J Obstet Gynecol       Date:  1998-12       Impact factor: 8.661

7.  Prediction of pre-eclampsia by abnormal uterine Doppler ultrasound and modification by aspirin.

Authors:  S J Bower; K F Harrington; K Schuchter; C McGirr; S Campbell
Journal:  Br J Obstet Gynaecol       Date:  1996-07

8.  The oxygen consumption/oxygen delivery curve in severe preeclampsia: evidence for a fixed oxygen extraction state.

Authors:  M A Belfort; J Anthony; G R Saade; N Wasserstrum; R Johanson; S Clark; K J Moise
Journal:  Am J Obstet Gynecol       Date:  1993-12       Impact factor: 8.661

9.  Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia.

Authors:  G Chen; S H Wang; H Z Zheng; J J Walker; J H McKillop
Journal:  Clin Exp Immunol       Date:  1996-04       Impact factor: 4.330

Review 10.  Bedrest compliance for women with pregnancy problems.

Authors:  L E Josten; K Savik; S E Mullett; R Campbell; P Vincent
Journal:  Birth       Date:  1995-03       Impact factor: 3.689

View more
  2 in total

Review 1.  Antihypertensive therapy in pregnancy.

Authors:  J G Umans; M D Lindheimer
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

2.  Magnesium in disease.

Authors:  Helmut Geiger; Christoph Wanner
Journal:  Clin Kidney J       Date:  2012-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.